PREEMPT’ing Overreliance on Peripheral Blood-Based ColoRectal Cancer Screening
Clin Chem. 2025 Dec 3:hvaf137. doi: 10.1093/clinchem/hvaf137. Online ahead of print. NO ABSTRACT PMID:41335517 | DOI:10.1093/clinchem/hvaf137

Clin Chem. 2025 Dec 3:hvaf137. doi: 10.1093/clinchem/hvaf137. Online ahead of print. NO ABSTRACT PMID:41335517 | DOI:10.1093/clinchem/hvaf137
Clin Chem. 2025 Dec 3:hvaf155. doi: 10.1093/clinchem/hvaf155. Online ahead of print. ABSTRACT BACKGROUND: Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) encompasses the use of antiviral medications to prevent HIV acquisition in individuals without HIV who are at risk. Currently available HIV PrEP medications are nucleoside reverse transcriptase inhibitors and integrase inhibitors. HIV testing is required … Read more
Clin Chem. 2025 Dec 3:hvaf161. doi: 10.1093/clinchem/hvaf161. Online ahead of print. NO ABSTRACT PMID:41335514 | DOI:10.1093/clinchem/hvaf161
Clin Chem. 2025 Dec 2:hvaf163. doi: 10.1093/clinchem/hvaf163. Online ahead of print. ABSTRACT BACKGROUND: Circulating cell-free DNA (cfDNA) fragmentomic features, such as fragment size and end motifs, have emerged as promising noninvasive biomarkers for cancer detection. However, the influence of nonmalignant clinical factors on these features remains unclear, potentially confounding liquid biopsy assays. METHODS: We analyzed … Read more
Clin Chem. 2025 Dec 2;71(12):1195-1199. doi: 10.1093/clinchem/hvaf097. NO ABSTRACT PMID:41329021 | DOI:10.1093/clinchem/hvaf097
Clin Chem. 2025 Dec 2;71(12):1200. doi: 10.1093/clinchem/hvaf117. NO ABSTRACT PMID:41329020 | DOI:10.1093/clinchem/hvaf117
Clin Chem. 2025 Dec 2;71(12):1201. doi: 10.1093/clinchem/hvaf130. NO ABSTRACT PMID:41329019 | DOI:10.1093/clinchem/hvaf130
Clin Chem. 2025 Dec 2;71(12):1281-1282. doi: 10.1093/clinchem/hvaf106. NO ABSTRACT PMID:41329018 | DOI:10.1093/clinchem/hvaf106
Clin Chem. 2025 Nov 19:hvaf132. doi: 10.1093/clinchem/hvaf132. Online ahead of print. NO ABSTRACT PMID:41259117 | DOI:10.1093/clinchem/hvaf132
Clin Chem. 2025 Nov 13:hvaf162. doi: 10.1093/clinchem/hvaf162. Online ahead of print. ABSTRACT BACKGROUND: Phosphorylated tau 217 (p-tau217) has emerged as a leading blood-based biomarker for Alzheimer disease (AD). While typically measured in plasma, serum is a widely used matrix in clinical laboratories, yet few p-tau217 assays have been validated for serum. Evaluating serum p-tau217 performance … Read more